Location History:
- Munchen, DE (1997)
- Munich, DE (2001)
Company Filing History:
Years Active: 1997-2001
Title: Axel Polack: Innovator in T Cell Stimulation
Introduction
Axel Polack is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunology, particularly in the stimulation of T cells with desired antigen specificity. His innovative approaches have led to the development of methods that enhance the effectiveness of T cell responses.
Latest Patents
Axel Polack holds 2 patents, with his latest inventions focusing on advanced techniques for T cell stimulation. One of his key patents is a method for the stimulation of T cells having a desired antigen specificity. This method involves several steps, including the introduction of immortalizing genes into antigen-presenting cells, allowing for the regulation of gene expression. The process continues with the introduction of a gene encoding the desired antigen, expanding the immortalized cells, and ultimately cultivating a mixture of leucocytic cells, including T cells, to stimulate the desired immune response.
Career Highlights
Polack is associated with the GSF-Forschungszentrum für Umwelt und Gesundheit, GmbH, where he conducts his research. His work has been pivotal in advancing the understanding of T cell dynamics and their application in therapeutic settings. His innovative methods have the potential to significantly impact cancer treatment and immunotherapy.
Collaborations
Throughout his career, Axel Polack has collaborated with esteemed colleagues, including Georg W. Bornkamm and Martin Staege. These collaborations have enriched his research and contributed to the development of groundbreaking techniques in immunology.
Conclusion
Axel Polack's contributions to the field of T cell stimulation exemplify the importance of innovation in medical research. His patents and collaborative efforts continue to pave the way for advancements in immunotherapy and cancer treatment.